Cargando…
Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy
The success of in vivo gene therapy greatly depends on the ability to control the immune response toward the therapeutic transgene. Over the last decade several vector-based and pharmacological approaches have been explored to control the immune-mediated clearance of transgene-expressing cells after...
Autores principales: | Goudy, Kevin Scott, Annoni, Andrea, Naldini, Luigi, Roncarolo, Maria-Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229161/ https://www.ncbi.nlm.nih.gov/pubmed/22144977 http://dx.doi.org/10.3389/fmicb.2011.00221 |
Ejemplares similares
-
Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice
por: Annoni, Andrea, et al.
Publicado: (2013) -
Gene therapy for ADA‐SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products
por: Aiuti, Alessandro, et al.
Publicado: (2017) -
The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
por: Gregori, Silvia, et al.
Publicado: (2012) -
Modulation of immune responses in lentiviral vector-mediated gene transfer
por: Annoni, Andrea, et al.
Publicado: (2019) -
Hepatocyte-Targeted Expression by Integrase-Defective Lentiviral Vectors Induces Antigen-Specific Tolerance in Mice with Low Genotoxic Risk
por: Mátrai, Janka, et al.
Publicado: (2011)